Maasstad Ziekenhuis Stichting

Burn Injury and Surgical Care

Clinical research activity is centered on burn injury, with attention to the perioperative management of patients undergoing burn excisional surgery and the associated risks of blood loss and transfusion needs.

  • Burn excision
  • Blood loss management
  • Allogeneic transfusion

This area reflects a focus on surgical care in severe thermal trauma and the haemostatic challenges linked to operative treatment.

Haemostasis and Fibrinolysis

Research interest includes the study of fibrinolysis during operative treatment for burns, with emphasis on understanding coagulation-related changes that may influence surgical bleeding.

  • Fibrinolytic activity
  • Coagulation balance
  • Intraoperative bleeding

The sponsor’s clinical activity in this domain is linked to improving knowledge of haemostatic responses in major burn surgery.

Antifibrinolytic Therapy

The trial portfolio includes interest in tranexamic acid as a therapy relevant to surgical blood conservation in patients with burn-related operative needs.

  • Tranexamic acid
  • Blood conservation
  • Surgical haemorrhage

This therapeutic domain is tied to reducing operative blood loss in a specialised trauma setting.

Hospital-based Clinical Research

As a hospital-based sponsor in Rotterdam, the research activity is concentrated within an acute care environment involving collaborating sites in the Netherlands.

  • Acute care
  • Multisite collaboration
  • Specialist surgical services

The clinical setting supports focused investigation of perioperative issues in patients with severe burns.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Tranexamic Acid and Sodium Chloride for Reducing Blood Loss in Patients Undergoing Burn Surgery

    Not recruiting

    3 1 1
    Investigated diseases:
    The Netherlands